Atsumi Nitta

Activities

Activities per year 1990 2003 2004 2005 2006 2007 2008 2009 2011 2013 2014 2016 2017 2018 2019

• 544 Oral presentation
• 41 social activities
• 8 Academic activities
• 3 Other educational activity
• 1 More
  • 1 Other reseach activity

Activities per year

Search results

• Tumor Necrosis Factor-α Protects Methamphetamine-Induced Drug Dependence and Neurotoxicity.

  Nitta, A. (Speaker)

  2004/10/23 → 2004/10/27

  Activity: Talk or presentation › Oral presentation

• Dual role of tumor necrosis factor α in the dependence and neurotoxicity induced by dextromethorphan.

  Nitta, A. (Speaker)

  2004/10/23 → 2004/10/27

  Activity: Talk or presentation › Oral presentation

• Hydrophobic dipeptide, Leu-Ile, protects against neuronal death by inducing BDNF and GDNF synthesis.

  Nitta, A. (Speaker)

  2004/10/23 → 2004/10/27

  Activity: Talk or presentation › Oral presentation

• Role of tissue plasminogen activator-plasmin system in the rewarding effect of morphine.

  Nitta, A. (Speaker)

  2004/10/23 → 2004/10/27

  Activity: Talk or presentation › Oral presentation

• 治験の品質管理における逸脱防止のための逸脱報告書の検討

  Nitta, A. (Speaker)

  2004/10/09 → 2004/10/10

  Activity: Talk or presentation › Oral presentation

• オピオイド系鎮痛薬と精神刺激薬に共通した依存形成の神経機構に関する研究‐神経経路網形成について‐.（シンポジウム2）

  Nitta, A. (Speaker)

  2004/09/24

  Activity: Talk or presentation › Oral presentation

• オピオイド系鎮痛薬と精神刺激薬に共通した依存形成の神経機構に関する研究‐治療薬の開発を目指して‐.（シンポジウム2）

  Nitta, A. (Speaker)

  2004/09/24

  Activity: Talk or presentation › Oral presentation

• Intracellular mechanisms involved in the neuroprotective effects of IGF-0 and Gingko biloba in cultured hippocampal neurons.

  Nitta, A. (Speaker)

  2004/09/21 → 2004/09/23

  Activity: Talk or presentation › Oral presentation

• Mechanism behind nuroprotection by propargylamines.(JSN-JSBPジョイントシンポジウム「薬剤による神経保護療法の現状と展望」）

  Nitta, A. (Speaker)

  2004/09/21 → 2004/09/23

  Activity: Talk or presentation › Oral presentation

• メタンフェタミン誘発行動障害における脳内MMP/TIMP システムの役割

  Nitta, A. (Speaker)

  2004/09/21 → 2004/09/23

  Activity: Talk or presentation › Oral presentation

• モルヒネ依存におけるLeu-Ile の抑制効果

  Nitta, A. (Speaker)

  2004/09/21 → 2004/09/23

  Activity: Talk or presentation › Oral presentation

• JSN-JSBPジョイントシンポジウム「薬剤による神経保護療法の現状と展望

  Nitta, A. (Speaker)

  2004/09/21 → 2004/09/23

  Activity: Talk or presentation › Oral presentation

• 疎水性ジペプチドLeu-Ileの神経保護作用

  Nitta, A. (Speaker)

  2004/09/21 → 2004/09/23

  Activity: Talk or presentation › Oral presentation

• サリドマイド＋デキサメタゾン併用療法の臨床試験に対する臨床治験管理センターの支援

  Nitta, A. (Speaker)

  2004/09/16 → 2004/09/18

  Activity: Talk or presentation › Oral presentation

• 覚醒剤および麻薬依存に共通する依存関連分子の検索.（セッション7「薬物依存研究の薬理学的戦略」）

  Nitta, A. (Speaker)

  2004/08/30 → 2004/09/01

  Activity: Talk or presentation › Oral presentation

• 統合失調症モデルマウスに認められる認知障害とCa2+/calmodulin kinaseⅡの関与

  Nitta, A. (Speaker)

  2004/07/23

  Activity: Talk or presentation › Oral presentation

• モルヒネ依存形成における疎水性ジペプチドLeu-Ileの役割

  Nitta, A. (Speaker)

  2004/07/23

  Activity: Talk or presentation › Oral presentation

• 疎水性ジペプチドLeu-Ileの神経保護および薬物依存抑制作用

  Nitta, A. (Speaker)

  2004/07/23

  Activity: Talk or presentation › Oral presentation

• t-PA is involved in morphine-induced rewarding effects.

  Nitta, A. (Speaker)

  2004/07/21 → 2004/07/23

  Activity: Talk or presentation › Oral presentation

• メタンフェタミンによる薬物依存に対するTNF-αおよびジペプチドの治療薬としての可能性.（ワークショップ「覚醒剤の過敏性変化は修復できるか」）

  Nitta, A. (Speaker)

  2004/07/21 → 2004/07/23

  Activity: Talk or presentation › Oral presentation

• 可塑的脳機能障害におけるニコチン性作動性神経系の役割（Ⅱ）.

  Nitta, A. (Speaker)

  2004/07/15

  Activity: Talk or presentation › Oral presentation

• タバコ成分中のカテコール化合物の神経栄養因子促進と神経保護効果‐培養海馬神経細胞における4-メチルカテコールによる遺伝子発現調節‐

  Nitta, A. (Speaker)

  2004/07/15

  Activity: Talk or presentation › Oral presentation

• メタンフェタミンの神経毒性に対する腫瘍壊死因子およびグリア細胞株由来神経栄養因子の影響.（シンポジウム9「薬物依存の分子機構」）

  Nitta, A. (Speaker)

  2004/07/06 → 2004/07/08

  Activity: Talk or presentation › Oral presentation

• フェンシクリジン連続投与によるグルタミン酸トランスポーターの発現変化

  Nitta, A. (Speaker)

  2004/07/03

  Activity: Talk or presentation › Oral presentation

• 神経変性疾患治療薬の開発を目指して.（特別講演）

  Nitta, A. (Speaker)

  2004/06/25

  Activity: Talk or presentation › Oral presentation

• methylprednisoloneがラット急性脊髄損傷におけるiNOSとapoptosisへ与える影響

  Nitta, A. (Speaker)

  2004/06/19

  Activity: Talk or presentation › Oral presentation

• モルヒネ依存に対する疎水性ジペプチドLeu-Ileの抑制効果

  Nitta, A. (Speaker)

  2004/06/19

  Activity: Talk or presentation › Oral presentation

• メタンフェタミンによって誘導される神経毒性に対するTNF-αおよびGDNFの影響

  Nitta, A. (Speaker)

  2004/06/19

  Activity: Talk or presentation › Oral presentation

• 損傷座骨神経の軸索再生に伴うグリア細胞由来神経栄養因子（GDNF）産生の径時的変化

  Nitta, A. (Speaker)

  2004/06/19

  Activity: Talk or presentation › Oral presentation

• ラット急性脊髄損傷モデルにおけるメチルプレドニゾロンのグリア細胞由来神経栄養因子産生に対する影響

  Nitta, A. (Speaker)

  2004/06/19

  Activity: Talk or presentation › Oral presentation

• メタンフェタミン誘発行動障害におけるMatrix metalloproteinase (MMP) / Tissue inhibitor of Matrix metalloproteinase (TIMP) システムの関与

  Nitta, A. (Speaker)

  2004/06/17 → 2004/06/18

  Activity: Talk or presentation › Oral presentation

• Tissue plasminogen activator (t-PA) is involved in morphine-induced rewarding effects.

  Nitta, A. (Speaker)

  2004/05/29

  Activity: Talk or presentation › Oral presentation

• Effects of Nicotine on Stress Response in Mice.

  Nitta, A. (Speaker)

  2004/05/29

  Activity: Talk or presentation › Oral presentation

• モルヒネ依存に対する疎水性ジペプチドLeu-Ileの抑制効果

  Nitta, A. (Speaker)

  2004/03/29 → 2004/03/31

  Activity: Talk or presentation › Oral presentation

• モルヒネの報酬効果における組織プラスミノーゲン活性化因子‐プラスミン系の関与（シンポジウム18「薬物依存の分子メカニズムと創薬への展望」）

  Nitta, A. (Speaker)

  2004/03/08 → 2004/03/10

  Activity: Talk or presentation › Oral presentation

• メタンフェタミン依存におけるLeu-Ileの治療効果

  Nitta, A. (Speaker)

  2004/03/08 → 2004/03/10

  Activity: Talk or presentation › Oral presentation

• Tissue plasminogen activator(tPA) is involved in morphine-induced rewarding effects in mice.

  Nitta, A. (Speaker)

  2004/02/19

  Activity: Talk or presentation › Oral presentation

• メタンフェタミン誘発行動障害におけるMatrix metalloproteinases（MMP）/ Tissue inhibitor of Matrix metalloproteinase（TIMP）システムの関与

  Nitta, A. (Speaker)

  2004/02/19

  Activity: Talk or presentation › Oral presentation

• メタンフェタミンの神経毒性に対する腫瘍壊死因子（TNF-α）関連治療薬の開発

  Nitta, A. (Speaker)

  2004/01/30

  Activity: Talk or presentation › Oral presentation

• Continuous infusion of GDNF can recover the functinal damaged following the spinal cord transection.

  Nitta, A. (Speaker)

  2005/11/12 → 2005/11/16

  Activity: Talk or presentation › Oral presentation

• Tissue plasminogen activator (tPA) knock-out mice overrespond to morphine self-administration mediated by dopamine D1 receptor.

  Nitta, A. (Speaker)

  2005/11/12 → 2005/11/16

  Activity: Talk or presentation › Oral presentation

• Reinstatement of methamphetamine-seeking behavior in C57BL/6J mice demonstrated by intravenous self-administration.

  Nitta, A. (Speaker)

  2005/11/12 → 2005/11/16

  Activity: Talk or presentation › Oral presentation

• フェンシクリジン連続投与マウスに認められる情動障害の発現における前頭前皮質グルタミン酸伝達系の関与

  Nitta, A. (Speaker)

  2005/11/11

  Activity: Talk or presentation › Oral presentation

• Leu-Ileをモルヒネによる依存症の新しい治療薬として用いる可能性について

  Nitta, A. (Speaker)

  2005/09/28 → 2005/09/30

  Activity: Talk or presentation › Oral presentation

• Actions of hydrophobic dipeptide Leu-Ile on the neuroprotection and drug dependence. （奨励賞受賞シンポジウム）

  Nitta, A. (Speaker)

  2005/09/28 → 2005/09/30

  Activity: Talk or presentation › Oral presentation

• Regulation of methamphetamine reward by ERK1/2Elk-1 signaling pathway via the activation of dopamine receptors.

  Nitta, A. (Speaker)

  2005/08/08

  Activity: Talk or presentation › Oral presentation

• Impairment of latent learning is correlated with a dysfunction of Ca2+/calmdulin kinase Ⅱ signaling in mice following withdrawal from repeated administration of phencyclidine.

  Nitta, A. (Speaker)

  2005/08/08

  Activity: Talk or presentation › Oral presentation

• A dipeptide, Leu-Ile, increases glial cell line-deprived neurotrophic factor expression through CREB activated by Hsp90/Akt signaling pathway.

  Nitta, A. (Speaker)

  2005/08/08

  Activity: Talk or presentation › Oral presentation

• Behavioral and neurobiochemical changes in olfactory bulbectomized rats: Antidepressive effects of sigma1 receptor agonist, SA-4503.

  Nitta, A. (Speaker)

  2005/08/08

  Activity: Talk or presentation › Oral presentation

• Involvement of GDNF and TNF-α in inhibitory effects of Leu-Ile on methamphetamine-induced dependence.

  Nitta, A. (Speaker)

  2005/08/08

  Activity: Talk or presentation › Oral presentation